;

Home >> Life Sciences >>

Global Chronic Kidney Disease Market Report 2020 - Industry Analysis Size Share Trends Segment and Forecasts to 2025 (Based on 2020 COVID-19 Analysis)

Published: Oct-2020 | Format: PDF | Maia Research | Number of pages: 115 | Code: MRS - 774243

The Chronic Kidney Disease market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Chronic Kidney Disease market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Chronic Kidney Disease market. The report focuses on well-known providers in the global Chronic Kidney Disease industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Chronic Kidney Disease Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Chronic Kidney Disease market covered in Chapter 4:
Johnson and Johnson
Kissei Pharmaceutical Co., Ltd
Teva Pharmaceutical Industries Ltd.
Eli Lilly and Co.
AbbVie, Inc.
FibroGen Inc
Abbott Laboratories
Pfizer, Inc.
Sanofi-Aventis
Allergan plc.
Amgen Inc.
Merck & Co.
AstraZeneca plc
Keryx Biopharmaceuticals, Inc.
Hoffmann-La Roche Ltd.
Eisai, Inc.
GlaxoSmithKline plc.

In Chapter 11 and 13.3, on the basis of types, the Chronic Kidney Disease market from 2015 to 2026 is primarily split into:
Drugs
Medical equipment

In Chapter 12 and 13.4, on the basis of applications, the Chronic Kidney Disease market from 2015 to 2026 covers:
Hospitals
Specialty clinics
Homecare

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Chronic Kidney Disease Market Share by Type (2020-2026)
1.5.2 Drugs
1.5.3 Medical equipment
1.6 Market by Application
1.6.1 Global Chronic Kidney Disease Market Share by Application (2020-2026)
1.6.2 Hospitals
1.6.3 Specialty clinics
1.6.4 Homecare
1.7 Chronic Kidney Disease Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Chronic Kidney Disease Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Chronic Kidney Disease Market
3.1 Value Chain Status
3.2 Chronic Kidney Disease Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Chronic Kidney Disease
3.2.3 Labor Cost of Chronic Kidney Disease
3.2.3.1 Labor Cost of Chronic Kidney Disease Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Johnson and Johnson
4.1.1 Johnson and Johnson Basic Information
4.1.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.1.3 Johnson and Johnson Chronic Kidney Disease Market Performance (2015-2020)
4.1.4 Johnson and Johnson Business Overview
4.2 Kissei Pharmaceutical Co., Ltd
4.2.1 Kissei Pharmaceutical Co., Ltd Basic Information
4.2.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.2.3 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Market Performance (2015-2020)
4.2.4 Kissei Pharmaceutical Co., Ltd Business Overview
4.3 Teva Pharmaceutical Industries Ltd.
4.3.1 Teva Pharmaceutical Industries Ltd. Basic Information
4.3.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.3.3 Teva Pharmaceutical Industries Ltd. Chronic Kidney Disease Market Performance (2015-2020)
4.3.4 Teva Pharmaceutical Industries Ltd. Business Overview
4.4 Eli Lilly and Co.
4.4.1 Eli Lilly and Co. Basic Information
4.4.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.4.3 Eli Lilly and Co. Chronic Kidney Disease Market Performance (2015-2020)
4.4.4 Eli Lilly and Co. Business Overview
4.5 AbbVie, Inc.
4.5.1 AbbVie, Inc. Basic Information
4.5.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.5.3 AbbVie, Inc. Chronic Kidney Disease Market Performance (2015-2020)
4.5.4 AbbVie, Inc. Business Overview
4.6 FibroGen Inc
4.6.1 FibroGen Inc Basic Information
4.6.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.6.3 FibroGen Inc Chronic Kidney Disease Market Performance (2015-2020)
4.6.4 FibroGen Inc Business Overview
4.7 Abbott Laboratories
4.7.1 Abbott Laboratories Basic Information
4.7.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.7.3 Abbott Laboratories Chronic Kidney Disease Market Performance (2015-2020)
4.7.4 Abbott Laboratories Business Overview
4.8 Pfizer, Inc.
4.8.1 Pfizer, Inc. Basic Information
4.8.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.8.3 Pfizer, Inc. Chronic Kidney Disease Market Performance (2015-2020)
4.8.4 Pfizer, Inc. Business Overview
4.9 Sanofi-Aventis
4.9.1 Sanofi-Aventis Basic Information
4.9.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.9.3 Sanofi-Aventis Chronic Kidney Disease Market Performance (2015-2020)
4.9.4 Sanofi-Aventis Business Overview
4.10 Allergan plc.
4.10.1 Allergan plc. Basic Information
4.10.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.10.3 Allergan plc. Chronic Kidney Disease Market Performance (2015-2020)
4.10.4 Allergan plc. Business Overview
4.11 Amgen Inc.
4.11.1 Amgen Inc. Basic Information
4.11.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.11.3 Amgen Inc. Chronic Kidney Disease Market Performance (2015-2020)
4.11.4 Amgen Inc. Business Overview
4.12 Merck & Co.
4.12.1 Merck & Co. Basic Information
4.12.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.12.3 Merck & Co. Chronic Kidney Disease Market Performance (2015-2020)
4.12.4 Merck & Co. Business Overview
4.13 AstraZeneca plc
4.13.1 AstraZeneca plc Basic Information
4.13.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.13.3 AstraZeneca plc Chronic Kidney Disease Market Performance (2015-2020)
4.13.4 AstraZeneca plc Business Overview
4.14 Keryx Biopharmaceuticals, Inc.
4.14.1 Keryx Biopharmaceuticals, Inc. Basic Information
4.14.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.14.3 Keryx Biopharmaceuticals, Inc. Chronic Kidney Disease Market Performance (2015-2020)
4.14.4 Keryx Biopharmaceuticals, Inc. Business Overview
4.15 Hoffmann-La Roche Ltd.
4.15.1 Hoffmann-La Roche Ltd. Basic Information
4.15.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.15.3 Hoffmann-La Roche Ltd. Chronic Kidney Disease Market Performance (2015-2020)
4.15.4 Hoffmann-La Roche Ltd. Business Overview
4.16 Eisai, Inc.
4.16.1 Eisai, Inc. Basic Information
4.16.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.16.3 Eisai, Inc. Chronic Kidney Disease Market Performance (2015-2020)
4.16.4 Eisai, Inc. Business Overview
4.17 GlaxoSmithKline plc.
4.17.1 GlaxoSmithKline plc. Basic Information
4.17.2 Chronic Kidney Disease Product Profiles, Application and Specification
4.17.3 GlaxoSmithKline plc. Chronic Kidney Disease Market Performance (2015-2020)
4.17.4 GlaxoSmithKline plc. Business Overview

5 Global Chronic Kidney Disease Market Analysis by Regions
5.1 Global Chronic Kidney Disease Sales, Revenue and Market Share by Regions
5.1.1 Global Chronic Kidney Disease Sales by Regions (2015-2020)
5.1.2 Global Chronic Kidney Disease Revenue by Regions (2015-2020)
5.2 North America Chronic Kidney Disease Sales and Growth Rate (2015-2020)
5.3 Europe Chronic Kidney Disease Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Chronic Kidney Disease Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Chronic Kidney Disease Sales and Growth Rate (2015-2020)
5.6 South America Chronic Kidney Disease Sales and Growth Rate (2015-2020)

6 North America Chronic Kidney Disease Market Analysis by Countries
6.1 North America Chronic Kidney Disease Sales, Revenue and Market Share by Countries
6.1.1 North America Chronic Kidney Disease Sales by Countries (2015-2020)
6.1.2 North America Chronic Kidney Disease Revenue by Countries (2015-2020)
6.1.3 North America Chronic Kidney Disease Market Under COVID-19
6.2 United States Chronic Kidney Disease Sales and Growth Rate (2015-2020)
6.2.1 United States Chronic Kidney Disease Market Under COVID-19
6.3 Canada Chronic Kidney Disease Sales and Growth Rate (2015-2020)
6.4 Mexico Chronic Kidney Disease Sales and Growth Rate (2015-2020)

7 Europe Chronic Kidney Disease Market Analysis by Countries
7.1 Europe Chronic Kidney Disease Sales, Revenue and Market Share by Countries
7.1.1 Europe Chronic Kidney Disease Sales by Countries (2015-2020)
7.1.2 Europe Chronic Kidney Disease Revenue by Countries (2015-2020)
7.1.3 Europe Chronic Kidney Disease Market Under COVID-19
7.2 Germany Chronic Kidney Disease Sales and Growth Rate (2015-2020)
7.2.1 Germany Chronic Kidney Disease Market Under COVID-19
7.3 UK Chronic Kidney Disease Sales and Growth Rate (2015-2020)
7.3.1 UK Chronic Kidney Disease Market Under COVID-19
7.4 France Chronic Kidney Disease Sales and Growth Rate (2015-2020)
7.4.1 France Chronic Kidney Disease Market Under COVID-19
7.5 Italy Chronic Kidney Disease Sales and Growth Rate (2015-2020)
7.5.1 Italy Chronic Kidney Disease Market Under COVID-19
7.6 Spain Chronic Kidney Disease Sales and Growth Rate (2015-2020)
7.6.1 Spain Chronic Kidney Disease Market Under COVID-19
7.7 Russia Chronic Kidney Disease Sales and Growth Rate (2015-2020)
7.7.1 Russia Chronic Kidney Disease Market Under COVID-19

8 Asia-Pacific Chronic Kidney Disease Market Analysis by Countries
8.1 Asia-Pacific Chronic Kidney Disease Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Chronic Kidney Disease Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Chronic Kidney Disease Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Chronic Kidney Disease Market Under COVID-19
8.2 China Chronic Kidney Disease Sales and Growth Rate (2015-2020)
8.2.1 China Chronic Kidney Disease Market Under COVID-19
8.3 Japan Chronic Kidney Disease Sales and Growth Rate (2015-2020)
8.3.1 Japan Chronic Kidney Disease Market Under COVID-19
8.4 South Korea Chronic Kidney Disease Sales and Growth Rate (2015-2020)
8.4.1 South Korea Chronic Kidney Disease Market Under COVID-19
8.5 Australia Chronic Kidney Disease Sales and Growth Rate (2015-2020)
8.6 India Chronic Kidney Disease Sales and Growth Rate (2015-2020)
8.6.1 India Chronic Kidney Disease Market Under COVID-19
8.7 Southeast Asia Chronic Kidney Disease Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Chronic Kidney Disease Market Under COVID-19

9 Middle East and Africa Chronic Kidney Disease Market Analysis by Countries
9.1 Middle East and Africa Chronic Kidney Disease Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Chronic Kidney Disease Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Chronic Kidney Disease Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Chronic Kidney Disease Market Under COVID-19
9.2 Saudi Arabia Chronic Kidney Disease Sales and Growth Rate (2015-2020)
9.3 UAE Chronic Kidney Disease Sales and Growth Rate (2015-2020)
9.4 Egypt Chronic Kidney Disease Sales and Growth Rate (2015-2020)
9.5 Nigeria Chronic Kidney Disease Sales and Growth Rate (2015-2020)
9.6 South Africa Chronic Kidney Disease Sales and Growth Rate (2015-2020)

10 South America Chronic Kidney Disease Market Analysis by Countries
10.1 South America Chronic Kidney Disease Sales, Revenue and Market Share by Countries
10.1.1 South America Chronic Kidney Disease Sales by Countries (2015-2020)
10.1.2 South America Chronic Kidney Disease Revenue by Countries (2015-2020)
10.1.3 South America Chronic Kidney Disease Market Under COVID-19
10.2 Brazil Chronic Kidney Disease Sales and Growth Rate (2015-2020)
10.2.1 Brazil Chronic Kidney Disease Market Under COVID-19
10.3 Argentina Chronic Kidney Disease Sales and Growth Rate (2015-2020)
10.4 Columbia Chronic Kidney Disease Sales and Growth Rate (2015-2020)
10.5 Chile Chronic Kidney Disease Sales and Growth Rate (2015-2020)

11 Global Chronic Kidney Disease Market Segment by Types
11.1 Global Chronic Kidney Disease Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Chronic Kidney Disease Sales and Market Share by Types (2015-2020)
11.1.2 Global Chronic Kidney Disease Revenue and Market Share by Types (2015-2020)
11.2 Drugs Sales and Price (2015-2020)
11.3 Medical equipment Sales and Price (2015-2020)

12 Global Chronic Kidney Disease Market Segment by Applications
12.1 Global Chronic Kidney Disease Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Chronic Kidney Disease Sales and Market Share by Applications (2015-2020)
12.1.2 Global Chronic Kidney Disease Revenue and Market Share by Applications (2015-2020)
12.2 Hospitals Sales, Revenue and Growth Rate (2015-2020)
12.3 Specialty clinics Sales, Revenue and Growth Rate (2015-2020)
12.4 Homecare Sales, Revenue and Growth Rate (2015-2020)

13 Chronic Kidney Disease Market Forecast by Regions (2020-2026)
13.1 Global Chronic Kidney Disease Sales, Revenue and Growth Rate (2020-2026)
13.2 Chronic Kidney Disease Market Forecast by Regions (2020-2026)
13.2.1 North America Chronic Kidney Disease Market Forecast (2020-2026)
13.2.2 Europe Chronic Kidney Disease Market Forecast (2020-2026)
13.2.3 Asia-Pacific Chronic Kidney Disease Market Forecast (2020-2026)
13.2.4 Middle East and Africa Chronic Kidney Disease Market Forecast (2020-2026)
13.2.5 South America Chronic Kidney Disease Market Forecast (2020-2026)
13.3 Chronic Kidney Disease Market Forecast by Types (2020-2026)
13.4 Chronic Kidney Disease Market Forecast by Applications (2020-2026)
13.5 Chronic Kidney Disease Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)3400 View Pricing